05:21 PM EDT, 07/31/2025 (MT Newswires) -- Bio-Rad Laboratories ( BIO/B ) reported Q2 adjusted EPS late Thursday of $2.61, down from $3.11 a year earlier.

Analysts polled by FactSet expected $1.73.

Revenue for the quarter ended June 30 was $651.6 million, compared with $638.5 million a year earlier.

Analysts surveyed by FactSet expected $615.2 million.

For the full year 2025, the company now expects non-GAAP, currency-neutral revenue growth of 0% to 1.0%, versus its prior guidance a 1.0% decline to 1.5% growth.

Non-GAAP operating margin is now estimated to be 12.0% to 13.0%, compared with 10.0% to 12.0% previously.

Shares were up over 11% in after-hours trading.